Gatt Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 16
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $11.4M
Latest Deal Amount
  • Investors
  • 3

Gatt General Information


Developer of surgical sealant and products designed to be used for controlling severe injuries. The company's medical products are developed using polymer-based general adhesive tissue tape for various surgical applications that helps in hemostasis for thin anticoagulated blood and also proper adhesion to wet tissues, enabling healthcare industry to avail body-destructible tape that can heal wounds and serve as a sealant after general surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Primary Office
  • Novio Tech Campus
  • Transistorweg 7
  • 6534 AT Nijmegen
  • Netherlands
+31 06 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gatt Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 18-May-2020 $11.4M 000.00 Completed Generating Revenue
1. Early Stage VC 02-Oct-2012 00.00 00.00 Completed Startup
To view Gatt’s complete valuation and funding history, request access »

Gatt Executive Team (7)

Name Title Board Seat Contact Info
Geert Gansewinkel Chief Executive Officer
André de Lege Chief Financial Officer
Johan Bender Founder and Chief Technology Officer
Rob Lips Chief Business Officer
Mark Giesbers Chief Learning Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Gatt Board Members (8)

Name Representing Role Since
Adrie Kuyper Gatt Board Member & Chairman of Supervisory Board 000 0000
Erik Hamminga Self Board Member 000 0000
Frans Rosmalen Self Board Member 000 0000
Jaap Kampinga Gatt Chairman 000 0000
Johan De Ruiter Gatt Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Gatt Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gatt Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Northstar Investments Limited Corporation Minority 000 0000 000000 0
Oost NL Venture Capital Minority 000 0000 000000 0
To view Gatt’s complete investors history, request access »